Xiong HQ - Search Results

1

Prostaglandin E2 drives cyclooxygenase-2 expression via cyclic AMP response element activation in human pancreatic cancer cells.

Pino MS, Nawrocki ST, Cognetti F, Abruzzese JL, Xiong HQ, McConkey DJ. Pino MS, et al. Among authors: xiong hq. Cancer Biol Ther. 2005 Nov;4(11):1263-9. doi: 10.4161/cbt.4.11.2138. Epub 2005 Dec 1. Cancer Biol Ther. 2005. PMID: 16319525 Free article.

2

Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.

Pino MS, Shrader M, Baker CH, Cognetti F, Xiong HQ, Abbruzzese JL, McConkey DJ. Pino MS, et al. Among authors: xiong hq. Cancer Res. 2006 Apr 1;66(7):3802-12. doi: 10.1158/0008-5472.CAN-05-3753. Cancer Res. 2006. PMID: 16585207

3

Novel therapies for pancreatic adenocarcinoma.

Pino SM, Xiong HQ, McConkey D, Abbruzzese JL. Pino SM, et al. Among authors: xiong hq. Curr Oncol Rep. 2004 May;6(3):199-206. doi: 10.1007/s11912-004-0050-1. Curr Oncol Rep. 2004. PMID: 15066231 Review.

4

Novel therapies for pancreatic adenocarcinoma.

Pino SM, Xiong HQ, McConkey D, Abbruzzese JL. Pino SM, et al. Among authors: xiong hq. Curr Gastroenterol Rep. 2004 Apr;6(2):119-25. doi: 10.1007/s11894-004-0038-x. Curr Gastroenterol Rep. 2004. PMID: 15191689 Review.

5

Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.

Davis DW, Takamori R, Raut CP, Xiong HQ, Herbst RS, Stadler WM, Heymach JV, Demetri GD, Rashid A, Shen Y, Wen S, Abbruzzese JL, McConkey DJ. Davis DW, et al. Among authors: xiong hq. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):678-89. Clin Cancer Res. 2005. PMID: 15701856

6

A phase I surrogate endpoint study of SU6668 in patients with solid tumors.

Xiong HQ, Herbst R, Faria SC, Scholz C, Davis D, Jackson EF, Madden T, McConkey D, Hicks M, Hess K, Charnsangavej CA, Abbruzzese JL. Xiong HQ, et al. Invest New Drugs. 2004 Nov;22(4):459-66. doi: 10.1023/B:DRUG.0000036688.96453.8d. Invest New Drugs. 2004. PMID: 15292716 Clinical Trial.

7

Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.

Wei D, Wang L, He Y, Xiong HQ, Abbruzzese JL, Xie K. Wei D, et al. Among authors: xiong hq. Cancer Res. 2004 Mar 15;64(6):2030-8. doi: 10.1158/0008-5472.can-03-1945. Cancer Res. 2004. PMID: 15026340

8

NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells.

Xiong HQ, Abbruzzese JL, Lin E, Wang L, Zheng L, Xie K. Xiong HQ, et al. Int J Cancer. 2004 Jan 10;108(2):181-8. doi: 10.1002/ijc.11562. Int J Cancer. 2004. PMID: 14639600

9

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.

Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K. Wei D, et al. Among authors: xiong hq. Oncogene. 2003 Jan 23;22(3):319-29. doi: 10.1038/sj.onc.1206122. Oncogene. 2003. PMID: 12545153

10

Experimental animal models of pancreatic carcinogenesis and metastasis.

Wei D, Xiong HQ, Abbruzzese JL, Xie K. Wei D, et al. Among authors: xiong hq. Int J Gastrointest Cancer. 2003;33(1):43-60. doi: 10.1385/IJGC:33:1:43. Int J Gastrointest Cancer. 2003. PMID: 12909737 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters